期刊文献+

奥硝唑注射液与头孢噻肟钠的配伍稳定性考察 被引量:10

Stability of compatibility of ornidazole injection and cefotaxime sodium for injection
在线阅读 下载PDF
导出
摘要 目的:采用RP-HPLC法考察4℃、25℃、37℃下24 h内奥硝唑注射液与注射用头孢噻肟钠的配伍稳定性。方法:采用Shimpack ODS色谱柱(4 mm×150 mm,5μm),流动相为甲醇∶水(60∶40),流速为0.5 mL/min,柱温25℃,检测波长为294 nm。结果:含奥硝唑50μg/mL和头孢噻肟钠100μg/mL的配伍液在4℃8 h、25℃4 h、37℃1 h内,外观及pH值无明显变化,奥硝唑的含量变化在5%以下,头孢噻肟钠的水解速率符合一级反应规律。结论:奥硝唑注射液与注射用头孢噻肟钠的配伍液在配伍后4℃8 h内、25℃4 h内、37℃1 h内可使用。 Objective: To evaluate the stability of compatibility of ornidazole injection and eefotaxime sodium for injection at 4℃, 25℃ and 37℃ for 24 h by RP-HPLC method. Methods: A Shimpack ODS column (4mm×150mm, 5μm) was used. The mobile phase was methanol water (60:40). The flow rate was 0.5 mL/min. The column temperature was 25℃ and the UV detection wavelength was 294 nm. Results: There were no significant changes in appearance and pH value of the compatible solution containing 50μg/mL ornidazole and 100μg/mL cefotaxime sodium at 4℃ for 8 h, 25℃ for 4 h and 37℃ for 1 h. The content of ornidazole decreased by less than 5% and the hydrolytic reaction rate of cefotaxime sodium conformed to the first order reaction kinetics. Conclusion: The mixture of ornidazole injection and cefotaxime sodium for injection can be used after storing at 4℃ for 8 h, 25℃ for 4 h and 37℃ for 1 h.
出处 《药学服务与研究》 CAS CSCD 2006年第2期136-138,共3页 Pharmaceutical Care and Research
关键词 奥硝唑 头孢噻肟钠 配伍 色谱法 高压液相 药物稳定性 ornidazole ceiotaxime sodium compatibility chromatography, high pressure liquid drug stability
作者简介 徐济萍(1961-),女(汉族),副主任药师 E-mail:xjp610510@163.com
  • 相关文献

参考文献1

二级参考文献15

  • 1[1]Lamp KC, Freeman CD, Klutman NE, et al.Pharmaco- kinetics and pharmacodynamics of the nitroimidazole antimicrobials[J].Clin Pharmacokinet,1999,36(5): 353.
  • 2[2]Munoz E, Castella J, Gutierrez JF.In vivo and in vitro sensitivity of Trichomonas gallinae to some nitroimidazole drugs[J].Vet Parasitol,1998,78(4): 239.
  • 3[3]Erenmemisoglu A, Tekol Y, Aydin N.Prophylactic effect of ornidazole on experimental tetanus in mice[J].Drugs Exp Clin Res, 1995,21(2): 59.
  • 4[4]Cedillo- Rivera R, Munoz O.In- vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents[J].J Med Microbiol, 1992,37(3):221.
  • 5[5]Okkan S, Atkovar G, Sahinler I,et al.A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results[J].Br J Cancer Suppl, 1996,27: 282.
  • 6[6]Oberlander G, Yeung CH, Cooper TG.Influence of oral administration of ornidazole on capacitation and the ac- tivity of some glycolytic enzymes of rat spermatozoa[J].J Reprod Fertil, 1996,106(2): 231.
  • 7[7]Bone W, Jones NG, Kamp G,et al.Effect of ornidazole on fertility of male rats: inhibition of a glycolysis- re lated motility pattern and zona binding required for fertilization in vitro[J].J Reprod Fertil,2000,118(1): 127.
  • 8[8]Yeung CH, Oberlander G, Cooper TG.Effects of the male antifertility agent ornidazole on sperm function in vitro and in the female genital tract[J].J Reprod Fertil, 1995,103(2): 257.
  • 9[9]Bourget P, Dechelette N, Fernandez H,et al.Dispositi- onof ornidazole and its metabolites during pregnancy[J].J Antimicrob Chemother,1995,35(5): 691.
  • 10[10]Heizmann P,Geschke R, Zinapold K.Determination of ONZ and its main metabolites in biological fluids[J].Journal of Chromatograpy, 1990,534: 223.

共引文献91

同被引文献82

引证文献10

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部